Search by Drug Name or NDC

    NDC 33342-0054-12 Pioglitazone 15 mg/1 Details

    Pioglitazone 15 mg/1

    Pioglitazone is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Macleods Pharmaceuticals Limited. The primary component is PIOGLITAZONE HYDROCHLORIDE.

    Product Information

    NDC 33342-0054
    Product ID 33342-054_7d118937-d5b2-402f-8e24-f70a48c1d432
    Associated GPIs 27607050100320
    GCN Sequence Number 042943
    GCN Sequence Number Description pioglitazone HCl TABLET 15 MG ORAL
    HIC3 C4N
    HIC3 Description ANTIHYPERGLYCEMIC,THIAZOLIDINEDIONE(PPARG AGONIST)
    GCN 92991
    HICL Sequence Number 020324
    HICL Sequence Number Description PIOGLITAZONE HCL
    Brand/Generic Generic
    Proprietary Name Pioglitazone
    Proprietary Name Suffix n/a
    Non-Proprietary Name Pioglitazone
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 15
    Active Ingredient Units mg/1
    Substance Name PIOGLITAZONE HYDROCHLORIDE
    Labeler Name Macleods Pharmaceuticals Limited
    Pharmaceutical Class PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA202467
    Listing Certified Through 2024-12-31

    Package

    NDC 33342-0054-12 (33342005412)

    NDC Package Code 33342-054-12
    Billing NDC 33342005412
    Package 100 TABLET in 1 BOX, UNIT-DOSE (33342-054-12)
    Marketing Start Date 2013-02-14
    NDC Exclude Flag N
    Pricing Information N/A